Global Sarcopenia Treatment Market Analysis 2025-2030: Growth Drivers, Challenges, And Opportunities

The Sarcopenia Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

How Big Is the Sarcopenia Treatment Market Size Expected to Be by 2034?
Over the past few years, there has been a robust growth in the market size of sarcopenia treatment. Starting from a value of $3.52 billion in 2024, it is predicted to increase to $3.73 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 6.1%. Key factors contributing to this historical growth include an aging population, heightened awareness and diagnosis, changes in lifestyle, public health campaigns, and regulatory approvals.

The size of the market for treating sarcopenia is forecasted to experience robust expansion in the near future. It is estimated to rise to a valuation of $4.72 billion by 2029, with a compound annual growth rate (CAGR) of 6.0%. The expected upturn during the projected timeline can be linked to factors like bespoke medicines, dietary modifications, incorporation of digital health platforms, an increase in patient awareness and autonomy, and worldwide health programs. The forecast period is also likely to witness key trends such as customized therapies, the introduction of innovative drug categories, the incorporation of digital health, collective research efforts, and ongoing research and development.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13926

What Are the Emerging Segments Within the Sarcopenia Treatment Market?
The sarcopenia treatment market covered in this report is segmented -

1) By Treatment Type: Protein Supplements, Vitamin B12 Supplements, Vitamin D And Calcium Supplements, Other Treatment Types
2) By Type: Primary Sarcopenia, Secondary Sarcopenia
3) By Route Of Administration: Oral, Parenteral, Enteral
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels

Subsegments:
1) By Protein Supplements: Whey Protein, Casein Protein, Soy Protein, Plant-Based Protein
2) By Vitamin B12 Supplements: Cyanocobalamin, Methylcobalamin
3) By Vitamin D And Calcium Supplements: Vitamin D2, Vitamin D3, Calcium Carbonate, Calcium Citrate
4) By Other Treatment Types: Exercise Programs, Hormone Replacement Therapy, Other Nutritional Interventions

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13926&type=smp

What Long-Term Drivers Are Shaping Sarcopenia Treatment Market Trends?
The escalation in instances of malnutrition is anticipated to stimulate the expansion of the sarcopenia treatment market in the future. Malnutrition collectively represents a lack, surplus, or inappropriate ratio in the consumption of energy and nutrients by an individual, inclusive of conditions like undernutrition, overweight, obesity, and illnesses associated with dietary habits. Sarcopenia treatment aims to resolve the overlapping issues of malnutrition and sarcopenia in elderly individuals using strategies such as nutritional therapy and physical activities. These strategies strive to enhance muscle mass, strength, and general nutritional health. As per a study issued by the World Health Organization (WHO), a United Nations (UN) institution based in Switzerland, in December 2023, malnutrition continues to represent a significant international health concern, with a projected 462 million people being underweight and 149 million children under 5 years of age experiencing stunting in 2022. As a result, the increasing prevalence of malnutrition is fueling the expansion of the sarcopenia treatment market.

Who Are the Top Competitors in Key Sarcopenia Treatment Market Segments?
Major companies operating in the sarcopenia treatment market report are Pfizer Inc., F-Hoffmann La-Roche, Merck Sharp & Dohme Corp. (Merck & Co.), AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Abbott Laboratories Inc., GlaxoSmithKline plc, Eli Lilly and Company, BASF SE, Nestle Health Science, Haleon Group of Companies, Regeneron Pharmaceuticals Inc., DSM, American Way (Amway) Corporation, Perrigo Company PLC, Intas Pharmaceuticals Ltd, Zydus Lifesciences, Fermenta Biotech Limited, Metagenics LLC, Ion Labs Inc., Makers Nutrition LLC, NutraScience Labs, AstaReal AB, NutraPak USA, BioThrive Sciences, Wellona Pharma, Healing Pharma India Pvt. Ltd., Nutrafill

What Are the Major Trends Shaping the Sarcopenia Treatment Market?
Leading firms in the sarcopenia treatment market are increasing their efforts to develop more advanced clinical study options for improved treatment methodologies. A clinical study is an organized research carried out on humans to evaluate the effectiveness, safety and outcomes of a medical procedure. For example, Biophytis, a biotech company in France, received authorization from the Food and Drug Administration (FDA) in September 2023 to begin the SARA-31 Phase 3 study on sarcopenia. The goal of the study is to assess the safety and effectiveness of Sarconeos (BIO101) in treating sarcopenic patients at risk of motor disability. This marked a considerable advancement in technological and pharmaceutical treatment strategies, proposing potential safety and efficacy benefits for severe sarcopenic patients. This is the inaugural phase 3 study in sarcopenia that was granted authorization by the FDA. The research will encompass approximately 900 sarcopenic patients, 65 years and older with low walking speed and weak grip strength. The main goal will be to evaluate the risk of major mobility disability (MMD), walking speed, hand grip strength, and self-reported patient quality of life.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/sarcopenia-treatment-global-market-report

Which Regions Are Becoming Hubs for Sarcopenia Treatment Market Innovation?
North America was the largest region in the sarcopenia treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sarcopenia treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Sarcopenia Treatment Market?
2. What is the CAGR expected in the Sarcopenia Treatment Market?
3. What Are the Key Innovations Transforming the Sarcopenia Treatment Industry?
4. Which Region Is Leading the Sarcopenia Treatment Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.